Efficacy of Biologics for Surgical Treatment of Periodontal Suprabony Defects: A Systematic Review and Meta‐Analysis of Controlled Clinical Trials
Journal of Clinical Periodontology · 2026-05 · 53 (5) · 735-751
DOI: 10.1111/jcpe.70078 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Clinical Periodontology, online erschienen am 14.01.2026. Verfasst von Sahar Baniameri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Biological Products, Alveolar Bone Loss. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
Limited bone support in suprabony defects hinders predictable regeneration, but adjunctive biologics can improve results. This systematic review and meta‐analysis aimed to evaluate the clinical efficacy of adjunctive biologics combined with open flap debridement (OFD) compared with OFD alone when treating suprabony defects. Materials and Methods A systematic literature search was performed to identify controlled trials evaluating adult patients presenting horizontal periodontal defects. The primary outcome included residual probing depth (PD). Random‐effects meta‐analyses were performed; heterogeneity was assessed using I 2 statistics; risk of bias was evaluated using Cochrane RoB‐2; and evidence of quality was appraised via the GRADE framework.
Results
Nine studies comprising 303 patients were included. Adjunctive use of biologics—including enamel matrix derivative (EMD), platelet‐rich fibrin (PRF) and hyaluronic acid (HA)—significantly enhanced clinical outcomes compared to OFD alone, with pooled mean differences favouring EMD and PRF for both residual PD (−0.89 and −0.42 mm) and clinical attachment level (CAL) (−1.32 and −0.69 mm). While subgroup differences were observed, notably with EMD, high heterogeneity was present for CAL and PD, and evidence of certainty ranged from low to very low.
Conclusion
Adjunctive biologics improve clinical outcomes in suprabony periodontal defects; however, rigorous standardised trials are needed for reaching firm conclusions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
- Center for Clinical Research and Evidence Synthesis in Oral Tissue Regeneration (CRITERION), Ann Arbor, Michigan, USA.
ORCID-Profile: Sahar Baniameri, Parham Hazrati, Hamoun Sabri, Abdusalam E Alrmali, Lucrezia Parma-Benfenati, Saeed A ElRefaei, Hom-Lay Wang, Muhammad H A Saleh
Zitieren
APA
Baniameri, S., Hazrati, P., Sabri, H., Alrmali, A. E., Parma-Benfenati, L., ElRefaei, S. A., Wang, H. L., & Saleh, M. H. A. (2026). Efficacy of Biologics for Surgical Treatment of Periodontal Suprabony Defects: A Systematic Review and Meta‐Analysis of Controlled Clinical Trials. Journal of Clinical Periodontology, 53(5), 735-751. https://doi.org/10.1111/jcpe.70078
Vancouver
Baniameri S, Hazrati P, Sabri H, Alrmali AE, Parma-Benfenati L, ElRefaei SA, et al. Efficacy of Biologics for Surgical Treatment of Periodontal Suprabony Defects: A Systematic Review and Meta‐Analysis of Controlled Clinical Trials. Journal of Clinical Periodontology. 2026;53(5):735-751. doi:10.1111/jcpe.70078
BibTeX
@article{Baniameri2026,
author = {Baniameri, Sahar and Hazrati, Parham and Sabri, Hamoun and Alrmali, Abdusalam E and Parma-Benfenati, Lucrezia and ElRefaei, Saeed A and Wang, Hom-Lay and Saleh, Muhammad H A},
title = {Efficacy of Biologics for Surgical Treatment of Periodontal Suprabony Defects: A Systematic Review and Meta‐Analysis of Controlled Clinical Trials},
journal = {Journal of Clinical Periodontology},
year = {2026},
volume = {53},
number = {5},
pages = {735--751},
doi = {10.1111/jcpe.70078}
}
EUVIMED